Iguana Healthcare Management’s Pfizer PFE Stock Holding History

Iguana Healthcare Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-52,700	Closed	-$1.81M	–	68
2017 Q4	$1.81M	Sell	52,700 -10,540	-17%	-$359K	1.18%	31
2017 Q3	$2.14M	Buy	+63,240	New	+$2.03M	1.17%	33
2016 Q4	–	Sell	-527,000	Closed	-$16.9M	–	77
2016 Q3	$16.9M	Buy	527,000 +316,200	+150%	+$10.6M	3.02%	8
2016 Q2	$7.04M	Hold	210,800	–	–	2.86%	8
2016 Q1	$5.93M	Buy	+210,800	New	+$6.02M	2.17%	15
2015 Q4	–	Sell	-316,200	Closed	-$9.42M	–	79
2015 Q3	$9.42M	Buy	316,200 +105,400	+50%	+$3.38M	3.71%	8
2015 Q2	$6.71M	Sell	210,800 -421,600	-67%	-$13.7M	2.12%	16
2015 Q1	$20.9M	Buy	632,400 +553,350	+700%	+$17.6M	8.78%	1
2014 Q4	$2.34M	Buy	+79,050	New	+$2.27M	1.13%	35
2014 Q2	–	Sell	-105,400	Closed	-$3.21M	–	85
2014 Q1	$3.21M	Buy	+105,400	New	+$3.14M	1.48%	25

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Iguana Healthcare Management's PFE Position: Q1 2018 in Review

Iguana Healthcare Management sold out of Pfizer (PFE) in Q1 2018, closing a stake of 52,700 shares — an estimated $1.81M sold.

Iguana Healthcare Management first reported a position in PFE in Q1 2014 and held it in 10 quarters. The position peaked at $20.9M in Q1 2015. 2,229 funds tracked by Wall St. Rank hold PFE as of Q1 2018.

Iguana Healthcare Management reported no remaining Pfizer position as of Q1 2018 after selling out during the quarter.
Iguana Healthcare Management sold 52,700 Pfizer shares in Q1 2018, an estimated $1.81M.
Iguana Healthcare Management first reported a position in Pfizer in Q1 2014 and held it in 10 quarters.
Iguana Healthcare Management's Pfizer position peaked at $20.9M in Q1 2015.
2,229 funds tracked by Wall St. Rank held Pfizer as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.